Introduction
Olmin is a prescription medication that contains two active ingredients: Olmesartan Medoxomil and Cilnidipine. It is available in tablet form and is primarily used to treat hypertension, also known as high blood pressure.
Uses
Olmin is prescribed to manage high blood pressure, which can help reduce the risk of heart disease, stroke, and other complications associated with hypertension. It is often recommended when lifestyle changes alone are not sufficient to control blood pressure.
Dosage and Administration
The dosage of Olmin may vary depending on the individual’s specific condition and response to treatment. Follow the instructions provided by your healthcare provider. Typically, the recommended starting dose is one tablet taken orally once daily. Your doctor may adjust the dosage as needed to achieve the desired blood pressure control.
Mechanism of Action
Olmin combines two different medications to help lower blood pressure. Olmesartan Medoxomil belongs to a class of drugs called angiotensin receptor blockers (ARBs), which work by blocking the action of a hormone called angiotensin II. This hormone normally causes blood vessels to narrow, leading to increased blood pressure. By blocking its action, Olmesartan Medoxomil helps relax and widen the blood vessels, reducing blood pressure. Cilnidipine, on the other hand, is a calcium channel blocker that works by relaxing the blood vessels and improving blood flow.
Side Effects
Common side effects may include dizziness, headache, swelling in the ankles or feet, and flushing. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, such as difficulty breathing, chest pain, or changes in vision, seek immediate medical attention.
Drug Interactions
Olmin may interact with certain medications, including other blood pressure-lowering drugs, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs). Inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs and supplements, to avoid potential interactions.
Precautions
Before taking Olmin, discuss your medical history and any existing conditions with your healthcare provider. Inform your doctor if you have a history of kidney or liver problems, heart disease, or if you are pregnant or planning to become pregnant. Olmin may not be suitable for everyone, and there may be certain contraindications or precautions to consider.
Storage
Olmin should be stored at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Do not use Olmin after the expiration date indicated on the packaging.
Patient Tips
Here are a few tips to help you make the most of your treatment with Olmin:
- Take the medication exactly as prescribed by your healthcare provider.
- If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule.
- Follow a healthy lifestyle, including a balanced diet, regular exercise, and stress management, to complement the effects of the medication.
- Keep regular appointments with your doctor to monitor your blood pressure and discuss any concerns or questions you may have.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Olmesartan: medicine to treat high blood pressure (NHS UK) [Accessed 3 Jun. 2024] (online) Available at:
- Olmesartan 10 mg film-coated tablets (Health Professionals SmPC) Available at:
- Cilnidipine (International database) (Drugs.com) [Accessed 2 Jun. 2024] (online) Available at:
- amlodipine-olmesartan (RX) [Accessed 25 Jun. 2024] (online) Available at:
- Olmesartan (MedlinePlus) [Accessed 13 Jun. 2024] (online) Available at:
- Chakraborty RN, Langade D, More S, Revandkar V, Birla A. Efficacy of Cilnidipine (L/N-type Calcium Channel Blocker) in Treatment of Hypertension: A Meta-Analysis of Randomized and Non-randomized Controlled Trials. Cureus. 2021 Nov 22;13(11):e19822. doi: 10.7759/cureus.19822. eCollection 2021 Nov. [Accessed 8 Jun. 2024] Available at:
Reviews
There are no reviews yet.